Global Drug Screening Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Drug Screening Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Immunoassay Analyzers
1.2.3 Chromatography
1.2.4 Breath Analyzers
1.2.5 Rapid Testing Devices
1.2.6 Assay Kits and Reagents
1.3 Market Segment by Application
1.3.1 Global Drug Screening Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals
1.3.3 Research Institute
1.3.4 Biotechnology & Pharmaceutical Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Drug Screening Market Size (2017-2028)
2.1.1 Global Drug Screening Revenue (2017-2028)
2.1.2 Global Drug Screening Sales (2017-2028)
2.2 Global Drug Screening Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Drug Screening Sales by Regions (2017-2022)
2.2.2 Global Drug Screening Revenue by Regions (2017-2022)
2.3 Global Drug Screening Market Size Forecast by Region
2.3.1 Global Drug Screening Sales Forecast by Region (2023-2028)
2.3.2 Global Drug Screening Revenue Forecast by Region (2023-2028)
2.4 Global Top Drug Screening Regions (Countries) Ranking by Market Size
2.5 Drug Screening Market Dynamics
2.5.1 Drug Screening Market Trends
2.5.2 Drug Screening Market Drivers
2.5.3 Drug Screening Market Challenges
2.5.4 Drug Screening Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Drug Screening Manufacturers by Sales (2017-2022)
3.1.1 Global Drug Screening Sales by Manufacturers (2017-2022)
3.1.2 Global Drug Screening Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Drug Screening Sales in 2021
3.2 Global Top Manufacturers Drug Screening by Revenue
3.2.1 Global Drug Screening Revenue by Manufacturers (2017-2022)
3.2.2 Top Drug Screening Manufacturers Covered: Ranking by Revenue
3.2.3 Global Drug Screening Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Drug Screening Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Screening as of 2021)
3.4 Global Drug Screening Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Drug Screening Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Drug Screening Market
3.7 Key Manufacturers Drug Screening Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Drug Screening Market Size by Type
4.1 Global Drug Screening Historic Market Review by Type (2017-2022)
4.1.1 Global Drug Screening Sales Market Share by Type (2017-2022)
4.1.2 Global Drug Screening Revenue Market Share by Type (2017-2022)
4.1.3 Drug Screening Price by Type (2017-2022)
4.2 Global Drug Screening Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Drug Screening Sales Forecast by Type (2023-2028)
4.2.2 Global Drug Screening Revenue Forecast by Type (2023-2028)
4.2.3 Drug Screening Price Forecast by Type (2023-2028)
5 Global Drug Screening Market Size by Application
5.1 Global Drug Screening Historic Market Review by Application (2017-2022)
5.1.1 Global Drug Screening Sales Market Share by Application (2017-2022)
5.1.2 Global Drug Screening Revenue Market Share by Application (2017-2022)
5.1.3 Drug Screening Price by Application (2017-2022)
5.2 Global Drug Screening Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Drug Screening Sales Forecast by Application (2023-2028)
5.2.2 Global Drug Screening Revenue Forecast by Application (2023-2028)
5.2.3 Drug Screening Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drug Screening Sales Breakdown by Company
6.1.1 North America Drug Screening Sales by Company (2017-2022)
6.1.2 North America Drug Screening Revenue by Company (2017-2022)
6.2 North America Drug Screening Market Size by Type
6.2.1 North America Drug Screening Sales by Type (2017-2028)
6.2.2 North America Drug Screening Revenue by Type (2017-2028)
6.3 North America Drug Screening Market Size by Application
6.3.1 North America Drug Screening Sales by Application (2017-2028)
6.3.2 North America Drug Screening Revenue by Application (2017-2028)
6.4 North America Drug Screening Market Size by Country
6.4.1 North America Drug Screening Sales by Country (2017-2028)
6.4.2 North America Drug Screening Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Drug Screening Sales Breakdown by Company
7.1.1 Europe Drug Screening Sales by Company (2017-2022)
7.1.2 Europe Drug Screening Revenue by Company (2017-2022)
7.2 Europe Drug Screening Market Size by Type
7.2.1 Europe Drug Screening Sales by Type (2017-2028)
7.2.2 Europe Drug Screening Revenue by Type (2017-2028)
7.3 Europe Drug Screening Market Size by Application
7.3.1 Europe Drug Screening Sales by Application (2017-2028)
7.3.2 Europe Drug Screening Revenue by Application (2017-2028)
7.4 Europe Drug Screening Market Size by Country
7.4.1 Europe Drug Screening Sales by Country (2017-2028)
7.4.2 Europe Drug Screening Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drug Screening Sales Breakdown by Company
8.1.1 Asia Pacific Drug Screening Sales by Company (2017-2022)
8.1.2 Asia Pacific Drug Screening Revenue by Company (2017-2022)
8.2 Asia Pacific Drug Screening Market Size by Type
8.2.1 Asia Pacific Drug Screening Sales by Type (2017-2028)
8.2.2 Asia Pacific Drug Screening Revenue by Type (2017-2028)
8.3 Asia Pacific Drug Screening Market Size by Application
8.3.1 Asia Pacific Drug Screening Sales by Application (2017-2028)
8.3.2 Asia Pacific Drug Screening Revenue by Application (2017-2028)
8.4 Asia Pacific Drug Screening Market Size by Region
8.4.1 Asia Pacific Drug Screening Sales by Region
8.4.2 Asia Pacific Drug Screening Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Drug Screening Sales Breakdown by Company
9.1.1 Latin America Drug Screening Sales by Company (2017-2022)
9.1.2 Latin America Drug Screening Revenue by Company (2017-2022)
9.2 Latin America Drug Screening Market Size by Type
9.2.1 Latin America Drug Screening Sales by Type (2017-2028)
9.2.2 Latin America Drug Screening Revenue by Type (2017-2028)
9.3 Latin America Drug Screening Market Size by Application
9.3.1 Latin America Drug Screening Sales by Application (2017-2028)
9.3.2 Latin America Drug Screening Revenue by Application (2017-2028)
9.4 Latin America Drug Screening Market Size by Country
9.4.1 Latin America Drug Screening Sales by Country (2017-2028)
9.4.2 Latin America Drug Screening Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Drug Screening Sales Breakdown by Company
10.1.1 Middle East and Africa Drug Screening Sales by Company (2017-2022)
10.1.2 Middle East and Africa Drug Screening Revenue by Company (2017-2022)
10.2 Middle East and Africa Drug Screening Market Size by Type
10.2.1 Middle East and Africa Drug Screening Sales by Type (2017-2028)
10.2.2 Middle East and Africa Drug Screening Revenue by Type (2017-2028)
10.3 Middle East and Africa Drug Screening Market Size by Application
10.3.1 Middle East and Africa Drug Screening Sales by Application (2017-2028)
10.3.2 Middle East and Africa Drug Screening Revenue by Application (2017-2028)
10.4 Middle East and Africa Drug Screening Market Size by Country
10.4.1 Middle East and Africa Drug Screening Sales by Country (2017-2028)
10.4.2 Middle East and Africa Drug Screening Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Overview
11.1.3 Abbott Drug Screening Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Abbott Drug Screening Products and Services
11.1.5 Abbott Drug Screening SWOT Analysis
11.1.6 Abbott Recent Developments
11.2 Express Diagnostics
11.2.1 Express Diagnostics Corporation Information
11.2.2 Express Diagnostics Overview
11.2.3 Express Diagnostics Drug Screening Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Express Diagnostics Drug Screening Products and Services
11.2.5 Express Diagnostics Drug Screening SWOT Analysis
11.2.6 Express Diagnostics Recent Developments
11.3 Laboratory Corporation of America
11.3.1 Laboratory Corporation of America Corporation Information
11.3.2 Laboratory Corporation of America Overview
11.3.3 Laboratory Corporation of America Drug Screening Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Laboratory Corporation of America Drug Screening Products and Services
11.3.5 Laboratory Corporation of America Drug Screening SWOT Analysis
11.3.6 Laboratory Corporation of America Recent Developments
11.4 MPD
11.4.1 MPD Corporation Information
11.4.2 MPD Overview
11.4.3 MPD Drug Screening Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 MPD Drug Screening Products and Services
11.4.5 MPD Drug Screening SWOT Analysis
11.4.6 MPD Recent Developments
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Corporation Information
11.5.2 Quest Diagnostics Overview
11.5.3 Quest Diagnostics Drug Screening Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Quest Diagnostics Drug Screening Products and Services
11.5.5 Quest Diagnostics Drug Screening SWOT Analysis
11.5.6 Quest Diagnostics Recent Developments
11.6 Roche Diagnostics
11.6.1 Roche Diagnostics Corporation Information
11.6.2 Roche Diagnostics Overview
11.6.3 Roche Diagnostics Drug Screening Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Roche Diagnostics Drug Screening Products and Services
11.6.5 Roche Diagnostics Drug Screening SWOT Analysis
11.6.6 Roche Diagnostics Recent Developments
11.7 Shimadzu
11.7.1 Shimadzu Corporation Information
11.7.2 Shimadzu Overview
11.7.3 Shimadzu Drug Screening Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Shimadzu Drug Screening Products and Services
11.7.5 Shimadzu Drug Screening SWOT Analysis
11.7.6 Shimadzu Recent Developments
11.8 Siemens Healthcare
11.8.1 Siemens Healthcare Corporation Information
11.8.2 Siemens Healthcare Overview
11.8.3 Siemens Healthcare Drug Screening Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Siemens Healthcare Drug Screening Products and Services
11.8.5 Siemens Healthcare Drug Screening SWOT Analysis
11.8.6 Siemens Healthcare Recent Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Corporation Information
11.9.2 Thermo Fisher Scientific Overview
11.9.3 Thermo Fisher Scientific Drug Screening Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Thermo Fisher Scientific Drug Screening Products and Services
11.9.5 Thermo Fisher Scientific Drug Screening SWOT Analysis
11.9.6 Thermo Fisher Scientific Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Drug Screening Value Chain Analysis
12.2 Drug Screening Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug Screening Production Mode & Process
12.4 Drug Screening Sales and Marketing
12.4.1 Drug Screening Sales Channels
12.4.2 Drug Screening Distributors
12.5 Drug Screening Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of TablesTable 1. Global Drug Screening Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Immunoassay Analyzers
Table 3. Major Manufacturers of Chromatography
Table 4. Major Manufacturers of Breath Analyzers
Table 5. Major Manufacturers of Rapid Testing Devices
Table 6. Major Manufacturers of Assay Kits and Reagents
Table 7. Global Drug Screening Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Drug Screening Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Drug Screening Sales by Region (2017-2022) & (K Units)
Table 10. Global Drug Screening Sales Market Share by Region (2017-2022)
Table 11. Global Drug Screening Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Drug Screening Revenue Market Share by Region (2017-2022)
Table 13. Global Drug Screening Sales Forecast by Region (2023-2028) & (K Units)
Table 14. Global Drug Screening Sales Market Share Forecast by Region (2023-2028)
Table 15. Global Drug Screening Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 16. Global Drug Screening Revenue Market Share Forecast by Region (2023-2028)
Table 17. Top Drug Screening Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 18. Drug Screening Market Trends
Table 19. Drug Screening Market Drivers
Table 20. Drug Screening Market Challenges
Table 21. Drug Screening Market Restraints
Table 22. Global Drug Screening Sales by Manufacturers (2017-2022) & (K Units)
Table 23. Global Drug Screening Sales Share by Manufacturers (2017-2022)
Table 24. Global Drug Screening Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Ranking of Global Top Drug Screening Manufacturers by Revenue (US$ Million) in 2021
Table 26. Drug Screening Revenue Share by Manufacturers (2017-2022)
Table 27. Global Drug Screening Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Screening as of 2021)
Table 29. Key Manufacturers Drug Screening Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 30. Key Manufacturers Drug Screening Plants/Factories Distribution
Table 31. Key Manufacturers Drug Screening Area Served
Table 32. Date of Key Manufacturers Enter into Drug Screening Market
Table 33. Key Manufacturers Drug Screening Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Drug Screening Sales (K Units) by Type (2017-2022)
Table 36. Global Drug Screening Sales Share by Type (2017-2022)
Table 37. Global Drug Screening Revenue (US$ Million) Market Share by Type (2017-2022)
Table 38. Global Drug Screening Price (K Units) by Type (2017-2022)
Table 39. Global Drug Screening Sales (K Units) by Type (2023-2028)
Table 40. Global Drug Screening Sales Share by Type (2023-2028)
Table 41. Global Drug Screening Revenue (US$ Million) Market Share by Type (2023-2028)
Table 42. Global Drug Screening Revenue Share by Type (2023-2028)
Table 43. Global Drug Screening Price (K Units) by Type (2023-2028)
Table 44. Global Drug Screening Sales (K Units) by Application (2017-2022)
Table 45. Global Drug Screening Sales Share by Application (2017-2022)
Table 46. Global Drug Screening Revenue (US$ Million) Market Share by Application (2017-2022)
Table 47. Global Drug Screening Price (K Units) by Application (2017-2022)
Table 48. Global Drug Screening Sales (K Units) by Application (2023-2028)
Table 49. Global Drug Screening Sales Share by Application (2023-2028)
Table 50. Global Drug Screening Revenue (US$ Million) Market Share by Application (2023-2028)
Table 51. Global Drug Screening Revenue Share by Application (2023-2028)
Table 52. Global Drug Screening Price (K Units) by Application (2023-2028)
Table 53. North America Drug Screening Sales by Company (2017-2022) & (K Units)
Table 54. North America Drug Screening Sales Market Share by Company (2017-2022)
Table 55. North America Drug Screening Revenue by Company (2017-2022) & (US$ Million)
Table 56. North America Drug Screening Revenue Market Share by Company (2017-2022)
Table 57. North America Drug Screening Sales by Type (2017-2022) & (K Units)
Table 58. North America Drug Screening Sales by Type (2023-2028) & (K Units)
Table 59. North America Drug Screening Revenue by Type (2017-2022) & (US$ Million)
Table 60. North America Drug Screening Revenue by Type (2023-2028) & (US$ Million)
Table 61. North America Drug Screening Sales by Application (2017-2022) & (K Units)
Table 62. North America Drug Screening Sales by Application (2023-2028) & (K Units)
Table 63. North America Drug Screening Revenue by Application (2017-2022) & (US$ Million)
Table 64. North America Drug Screening Revenue by Application (2023-2028) & (US$ Million)
Table 65. North America Drug Screening Sales by Country (2017-2022) & (K Units)
Table 66. North America Drug Screening Sales by Country (2023-2028) & (K Units)
Table 67. North America Drug Screening Revenue by Country (2017-2022) & (US$ Million)
Table 68. North America Drug Screening Revenue by Country (2023-2028) & (US$ Million)
Table 69. Europe Drug Screening Sales by Company (2017-2022) & (K Units)
Table 70. Europe Drug Screening Sales Market Share by Company (2017-2022)
Table 71. Europe Drug Screening Revenue by Company (2017-2022) & (US$ Million)
Table 72. Europe Drug Screening Revenue Market Share by Company (2017-2022)
Table 73. Europe Drug Screening Sales by Type (2017-2022) & (K Units)
Table 74. Europe Drug Screening Sales by Type (2023-2028) & (K Units)
Table 75. Europe Drug Screening Revenue by Type (2017-2022) & (US$ Million)
Table 76. Europe Drug Screening Revenue by Type (2023-2028) & (US$ Million)
Table 77. Europe Drug Screening Sales by Application (2017-2022) & (K Units)
Table 78. Europe Drug Screening Sales by Application (2023-2028) & (K Units)
Table 79. Europe Drug Screening Revenue by Application (2017-2022) & (US$ Million)
Table 80. Europe Drug Screening Revenue by Application (2023-2028) & (US$ Million)
Table 81. Europe Drug Screening Sales by Country (2017-2022) & (K Units)
Table 82. Europe Drug Screening Sales by Country (2023-2028) & (K Units)
Table 83. Europe Drug Screening Revenue by Country (2017-2022) & (US$ Million)
Table 84. Europe Drug Screening Revenue by Country (2023-2028) & (US$ Million)
Table 85. Asia Pacific Drug Screening Sales by Company (2017-2022) & (K Units)
Table 86. Asia Pacific Drug Screening Sales Market Share by Company (2017-2022)
Table 87. Asia Pacific Drug Screening Revenue by Company (2017-2022) & (US$ Million)
Table 88. Asia Pacific Drug Screening Revenue Market Share by Company (2017-2022)
Table 89. Asia Pacific Drug Screening Sales by Type (2017-2022) & (K Units)
Table 90. Asia Pacific Drug Screening Sales by Type (2023-2028) & (K Units)
Table 91. Asia Pacific Drug Screening Revenue by Type (2017-2022) & (US$ Million)
Table 92. Asia Pacific Drug Screening Revenue by Type (2023-2028) & (US$ Million)
Table 93. Asia Pacific Drug Screening Sales by Application (2017-2022) & (K Units)
Table 94. Asia Pacific Drug Screening Sales by Application (2023-2028) & (K Units)
Table 95. Asia Pacific Drug Screening Revenue by Application (2017-2022) & (US$ Million)
Table 96. Asia Pacific Drug Screening Revenue by Application (2023-2028) & (US$ Million)
Table 97. Asia Pacific Drug Screening Sales by Region (2017-2022) & (K Units)
Table 98. Asia Pacific Drug Screening Sales by Region (2023-2028) & (K Units)
Table 99. Asia Pacific Drug Screening Revenue by Region (2017-2022) & (US$ Million)
Table 100. Asia Pacific Drug Screening Revenue by Region (2023-2028) & (US$ Million)
Table 101. Latin America Drug Screening Sales by Company (2017-2022) & (K Units)
Table 102. Latin America Drug Screening Sales Market Share by Company (2017-2022)
Table 103. Latin America Drug Screening Revenue by Company (2017-2022) & (US$ Million)
Table 104. Latin America Drug Screening Revenue Market Share by Company (2017-2022)
Table 105. Latin America Drug Screening Sales by Type (2017-2022) & (K Units)
Table 106. Latin America Drug Screening Sales by Type (2023-2028) & (K Units)
Table 107. Latin America Drug Screening Revenue by Type (2017-2022) & (US$ Million)
Table 108. Latin America Drug Screening Revenue by Type (2023-2028) & (US$ Million)
Table 109. Latin America Drug Screening Sales by Application (2017-2022) & (K Units)
Table 110. Latin America Drug Screening Sales by Application (2023-2028) & (K Units)
Table 111. Latin America Drug Screening Revenue by Application (2017-2022) & (US$ Million)
Table 112. Latin America Drug Screening Revenue by Application (2023-2028) & (US$ Million)
Table 113. Latin America Drug Screening Sales by Country (2017-2022) & (K Units)
Table 114. Latin America Drug Screening Sales by Country (2023-2028) & (K Units)
Table 115. Latin America Drug Screening Revenue by Country (2017-2022) & (US$ Million)
Table 116. Latin America Drug Screening Revenue by Country (2023-2028) & (US$ Million)
Table 117. Middle East and Africa Drug Screening Sales by Company (2017-2022) & (K Units)
Table 118. Middle East and Africa Drug Screening Sales Market Share by Company (2017-2022)
Table 119. Middle East and Africa Drug Screening Revenue by Company (2017-2022) & (US$ Million)
Table 120. Middle East and Africa Drug Screening Revenue Market Share by Company (2017-2022)
Table 121. Middle East and Africa Drug Screening Sales by Type (2017-2022) & (K Units)
Table 122. Middle East and Africa Drug Screening Sales by Type (2023-2028) & (K Units)
Table 123. Middle East and Africa Drug Screening Revenue by Type (2017-2022) & (US$ Million)
Table 124. Middle East and Africa Drug Screening Revenue by Type (2023-2028) & (US$ Million)
Table 125. Middle East and Africa Drug Screening Sales by Application (2017-2022) & (K Units)
Table 126. Middle East and Africa Drug Screening Sales by Application (2023-2028) & (K Units)
Table 127. Middle East and Africa Drug Screening Revenue by Application (2017-2022) & (US$ Million)
Table 128. Middle East and Africa Drug Screening Revenue by Application (2023-2028) & (US$ Million)
Table 129. Middle East and Africa Drug Screening Sales by Country (2017-2022) & (K Units)
Table 130. Middle East and Africa Drug Screening Sales by Country (2023-2028) & (K Units)
Table 131. Middle East and Africa Drug Screening Revenue by Country (2017-2022) & (US$ Million)
Table 132. Middle East and Africa Drug Screening Revenue by Country (2023-2028) & (US$ Million)
Table 133. Abbott Corporation Information
Table 134. Abbott Description and Overview
Table 135. Abbott Drug Screening Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 136. Abbott Drug Screening Product and Services
Table 137. Abbott Drug Screening SWOT Analysis
Table 138. Abbott Recent Developments
Table 139. Express Diagnostics Corporation Information
Table 140. Express Diagnostics Description and Overview
Table 141. Express Diagnostics Drug Screening Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 142. Express Diagnostics Drug Screening Product and Services
Table 143. Express Diagnostics Drug Screening SWOT Analysis
Table 144. Express Diagnostics Recent Developments
Table 145. Laboratory Corporation of America Corporation Information
Table 146. Laboratory Corporation of America Description and Overview
Table 147. Laboratory Corporation of America Drug Screening Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 148. Laboratory Corporation of America Drug Screening Product and Services
Table 149. Laboratory Corporation of America Drug Screening SWOT Analysis
Table 150. Laboratory Corporation of America Recent Developments
Table 151. MPD Corporation Information
Table 152. MPD Description and Overview
Table 153. MPD Drug Screening Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 154. MPD Drug Screening Product and Services
Table 155. MPD Drug Screening SWOT Analysis
Table 156. MPD Recent Developments
Table 157. Quest Diagnostics Corporation Information
Table 158. Quest Diagnostics Description and Overview
Table 159. Quest Diagnostics Drug Screening Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 160. Quest Diagnostics Drug Screening Product and Services
Table 161. Quest Diagnostics Drug Screening SWOT Analysis
Table 162. Quest Diagnostics Recent Developments
Table 163. Roche Diagnostics Corporation Information
Table 164. Roche Diagnostics Description and Overview
Table 165. Roche Diagnostics Drug Screening Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 166. Roche Diagnostics Drug Screening Product and Services
Table 167. Roche Diagnostics Drug Screening SWOT Analysis
Table 168. Roche Diagnostics Recent Developments
Table 169. Shimadzu Corporation Information
Table 170. Shimadzu Description and Overview
Table 171. Shimadzu Drug Screening Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 172. Shimadzu Drug Screening Product and Services
Table 173. Shimadzu Drug Screening SWOT Analysis
Table 174. Shimadzu Recent Developments
Table 175. Siemens Healthcare Corporation Information
Table 176. Siemens Healthcare Description and Overview
Table 177. Siemens Healthcare Drug Screening Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 178. Siemens Healthcare Drug Screening Product and Services
Table 179. Siemens Healthcare Drug Screening SWOT Analysis
Table 180. Siemens Healthcare Recent Developments
Table 181. Thermo Fisher Scientific Corporation Information
Table 182. Thermo Fisher Scientific Description and Overview
Table 183. Thermo Fisher Scientific Drug Screening Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 184. Thermo Fisher Scientific Drug Screening Product and Services
Table 185. Thermo Fisher Scientific Drug Screening SWOT Analysis
Table 186. Thermo Fisher Scientific Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Drug Screening Distributors List
Table 190. Drug Screening Customers List
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of FiguresFigure 1. Drug Screening Product Picture
Figure 2. Global Drug Screening Sales Market Share by Type in 2021 & 2028
Figure 3. Immunoassay Analyzers Product Picture
Figure 4. Chromatography Product Picture
Figure 5. Breath Analyzers Product Picture
Figure 6. Rapid Testing Devices Product Picture
Figure 7. Assay Kits and Reagents Product Picture
Figure 8. Global Drug Screening Sales Market Share by Application in 2021 & 2028
Figure 9. Hospitals Use Case
Figure 10. Research Institute Use Case
Figure 11. Biotechnology & Pharmaceutical Companies Use Case
Figure 12. Others Use Case
Figure 13. Drug Screening Report Years Considered
Figure 14. Global Drug Screening Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Drug Screening Market Size 2017-2028 (US$ Million)
Figure 16. Global Drug Screening Sales (2017-2022) & (K Units)
Figure 17. Global Drug Screening Market Size Market Share by Region: 2021 VS 2028
Figure 18. Global Drug Screening Sales Market Share by Region (2017-2022)
Figure 19. Global Drug Screening Sales Market Share by Region in 2021
Figure 20. Global Drug Screening Revenue Market Share by Region in 2017 VS 2021
Figure 21. Global Drug Screening Sales Share by Manufacturers in 2021
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Drug Screening Sales in 2021
Figure 23. Drug Screening Revenue Share by Manufacturers in 2021
Figure 24. Drug Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 25. Global Drug Screening Revenue Share by Type (2017-2022)
Figure 26. Global Drug Screening Revenue Growth Rate by Type in 2017 & 2021
Figure 27. Global Drug Screening Revenue Share by Application (2017-2022)
Figure 28. Global Drug Screening Revenue Growth Rate by Application in 2017 & 2021
Figure 29. North America Drug Screening Sales Market Share by Type (2017-2028)
Figure 30. North America Drug Screening Revenue Market Share by Type (2017-2028)
Figure 31. North America Drug Screening Sales Market Share by Application (2017-2028)
Figure 32. North America Drug Screening Revenue Market Share by Application (2017-2028)
Figure 33. North America Drug Screening Sales Share by Country (2017-2028)
Figure 34. North America Drug Screening Revenue Share by Country (2017-2028)
Figure 35. U.S. Drug Screening Revenue (2017-2028) & (US$ Million)
Figure 36. Canada Drug Screening Revenue (2017-2028) & (US$ Million)
Figure 37. Europe Drug Screening Sales Market Share by Type (2017-2028)
Figure 38. Europe Drug Screening Revenue Market Share by Type (2017-2028)
Figure 39. Europe Drug Screening Sales Market Share by Application (2017-2028)
Figure 40. Europe Drug Screening Revenue Market Share by Application (2017-2028)
Figure 41. Europe Drug Screening Sales Share by Country (2017-2028)
Figure 42. Europe Drug Screening Revenue Share by Country (2017-2028)
Figure 43. Germany Drug Screening Revenue (2017-2028) & (US$ Million)
Figure 44. France Drug Screening Revenue (2017-2028) & (US$ Million)
Figure 45. U.K. Drug Screening Revenue (2017-2028) & (US$ Million)
Figure 46. Italy Drug Screening Revenue (2017-2028) & (US$ Million)
Figure 47. Russia Drug Screening Revenue (2017-2028) & (US$ Million)
Figure 48. Asia Pacific Drug Screening Sales Market Share by Type (2017-2028)
Figure 49. Asia Pacific Drug Screening Revenue Market Share by